Tapewire

Nasdaq · USD

INO

INOVIO PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
6589
SEC CIK
0001055726
Parsed reports
298

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 10, 2024 Filed May 13, 2024 20:57 UTC
Shea Jacqueline ElizabethDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-24-000022 · wk-form4_1715633831.xml · nonDerivative · entry 1

Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,012

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units is as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · balance_after: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 28, 2024 Filed Feb 28, 2024 22:09 UTC
Shea Jacqueline ElizabethDirector · Chief Executive Officer
GrantRestricted Stock Unit · Derivative 55,895 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000005 · wk-form4_1709158138.xml · derivative · entry 8

Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,895

Underlying: Common Stock · 55,895 shares

Expires not disclosed

F7 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units is as follows: 18,632 shares will vest on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F7 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units is as follows: 18,632 shares will vest on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F7 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units is as follows: 18,632 shares will vest on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Read SEC document
February 28, 2024 Filed Feb 28, 2024 22:09 UTC
Shea Jacqueline ElizabethDirector · Chief Executive Officer
GrantCommon Stock Option · Derivative 69,733 $0.00 Strike: $8.46 $0.00
Disclosure

SEC source: 0001055726-24-000005 · wk-form4_1709158138.xml · derivative · entry 7

Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,733

Underlying: Common Stock · 69,733 shares

Expires 2034-02-28

F6 · derivative.exercise_date: The vesting schedule for the 69,733 options is as follows: 17,434 shares vested on February 28, 2024; 17,433 shares will vest on February 28, 2025; 17,433 shares will vest on February 28, 2026; and 17,433 shares will vest on February 28, 2027.

Read SEC document
February 28, 2024 Filed Feb 28, 2024 22:07 UTC
Humeau LaurentChief Scientific Officer
GrantRestricted Stock Unit · Derivative 15,029 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000004 · wk-form4_1709158046.xml · derivative · entry 8

Humeau Laurent · CIK 0001770390 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,029

Underlying: Common Stock · 15,029 shares

Expires not disclosed

F7 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F7 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F7 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Read SEC document
February 28, 2024 Filed Feb 28, 2024 22:07 UTC
Humeau LaurentChief Scientific Officer
GrantCommon Stock Option · Derivative 18,750 $0.00 Strike: $8.46 $0.00
Disclosure

SEC source: 0001055726-24-000004 · wk-form4_1709158046.xml · derivative · entry 7

Humeau Laurent · CIK 0001770390 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,750

Underlying: Common Stock · 18,750 shares

Expires 2034-02-28

F6 · derivative.exercise_date: The vesting schedule for the 18,750 options is as follows: 4,688 shares vested on February 28, 2024; 4,688 shares will vest on February 28, 2025; 4,687 shares will vest on February 28, 2026; and 4,687 shares will vest on February 28, 2027.

Read SEC document
February 28, 2024 Filed Feb 28, 2024 22:06 UTC GrantRestricted Stock Unit · Derivative 15,029 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000003 · wk-form4_1709157959.xml · derivative · entry 9

KIES PETER · CIK 0001259780 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,029

Underlying: Common Stock · 15,029 shares

Expires not disclosed

F7 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F7 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F7 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Read SEC document
February 28, 2024 Filed Feb 28, 2024 22:06 UTC GrantCommon Stock Option · Derivative 18,750 $0.00 Strike: $8.46 $0.00
Disclosure

SEC source: 0001055726-24-000003 · wk-form4_1709157959.xml · derivative · entry 8

KIES PETER · CIK 0001259780 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,750

Underlying: Common Stock · 18,750 shares

Expires 2034-02-28

F6 · derivative.exercise_date: The vesting schedule for the 18,750 options is as follows: 4,688 shares vested on February 28, 2024; 4,688 shares will vest on February 28, 2025; 4,687 shares will vest on February 28, 2026; and 4,687 shares will vest on February 28, 2027.

Read SEC document
February 28, 2024 Filed Feb 28, 2024 22:03 UTC
Sumner Michael JohnChief Medical Officer
GrantRestricted Stock Unit · Derivative 15,029 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000002 · wk-form4_1709157796.xml · derivative · entry 2

Sumner Michael John · CIK 0001936799 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,029

Underlying: Common Stock · 15,029 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Read SEC document
February 28, 2024 Filed Feb 28, 2024 22:03 UTC
Sumner Michael JohnChief Medical Officer
GrantCommon Stock Option · Derivative 18,750 $0.00 Strike: $8.46 $0.00
Disclosure

SEC source: 0001055726-24-000002 · wk-form4_1709157796.xml · derivative · entry 1

Sumner Michael John · CIK 0001936799 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,750

Underlying: Common Stock · 18,750 shares

Expires 2034-02-28

F1 · derivative.exercise_date: The vesting schedule for the 18,750 options is as follows: 4,688 shares vested on February 28, 2024; 4,688 shares will vest on February 28, 2025; 4,687 shares will vest on February 28, 2026; and 4,687 shares will vest on February 28, 2027.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:10 UTC Exercise / conversionRestricted Stock Unit · Derivative 972 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000006 · wk-form4_1709158215.xml · derivative · entry 6

Weiner David B. · CIK 0001669080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,944

Underlying: Common Stock · 972 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares will vest on February 26, 2025; and 972 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares will vest on February 26, 2025; and 972 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares will vest on February 26, 2025; and 972 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · derivative.underlying_shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F2 · balance_after: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:10 UTC Exercise / conversionRestricted Stock Unit · Derivative 972 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000006 · wk-form4_1709158215.xml · derivative · entry 5

Weiner David B. · CIK 0001669080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 972

Underlying: Common Stock · 972 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · derivative.underlying_shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F2 · balance_after: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:10 UTC Exercise / conversionRestricted Stock Unit · Derivative 972 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000006 · wk-form4_1709158215.xml · derivative · entry 4

Weiner David B. · CIK 0001669080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 972 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units was as follows: 972 shares vested on February 26, 2022; 972 shares vested on February 26, 2023; and 972 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F2 · shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units was as follows: 972 shares vested on February 26, 2022; 972 shares vested on February 26, 2023; and 972 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units was as follows: 972 shares vested on February 26, 2022; 972 shares vested on February 26, 2023; and 972 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F2 · derivative.underlying_shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:10 UTC Exercise / conversionCommon Stock 972 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-24-000006 · wk-form4_1709158215.xml · nonDerivative · entry 3

Weiner David B. · CIK 0001669080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,343

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares will vest on February 26, 2025; and 972 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:10 UTC Exercise / conversionCommon Stock 972 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-24-000006 · wk-form4_1709158215.xml · nonDerivative · entry 2

Weiner David B. · CIK 0001669080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,371

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:10 UTC Exercise / conversionCommon Stock 972 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-24-000006 · wk-form4_1709158215.xml · nonDerivative · entry 1

Weiner David B. · CIK 0001669080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,399

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units was as follows: 972 shares vested on February 26, 2022; 972 shares vested on February 26, 2023; and 972 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F2 · balance_after: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:09 UTC
Shea Jacqueline ElizabethDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Unit · Derivative 5,853 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000005 · wk-form4_1709158138.xml · derivative · entry 6

Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,852

Underlying: Common Stock · 5,853 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 17,557 restricted stock units is as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 17,557 restricted stock units is as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 17,557 restricted stock units is as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · derivative.underlying_shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F2 · balance_after: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:09 UTC
Shea Jacqueline ElizabethDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Unit · Derivative 1,878 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000005 · wk-form4_1709158138.xml · derivative · entry 5

Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,878 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F2 · shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F2 · derivative.underlying_shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:09 UTC
Shea Jacqueline ElizabethDirector · Chief Executive Officer
Tax withholdingCommon Stock 2,856 $8.16 $23,304.96
Disclosure

SEC source: 0001055726-24-000005 · wk-form4_1709158138.xml · nonDerivative · entry 4

Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,512

F5 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (4) herein.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:09 UTC
Shea Jacqueline ElizabethDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,853 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-24-000005 · wk-form4_1709158138.xml · nonDerivative · entry 3

Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,368

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 17,557 restricted stock units is as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:09 UTC
Shea Jacqueline ElizabethDirector · Chief Executive Officer
Tax withholdingCommon Stock 872 $8.16 $7,115.52
Disclosure

SEC source: 0001055726-24-000005 · wk-form4_1709158138.xml · nonDerivative · entry 2

Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,515

F3 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:09 UTC
Shea Jacqueline ElizabethDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,878 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-24-000005 · wk-form4_1709158138.xml · nonDerivative · entry 1

Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,387

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F2 · balance_after: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:07 UTC
Humeau LaurentChief Scientific Officer
Exercise / conversionRestricted Stock Unit · Derivative 3,856 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000004 · wk-form4_1709158046.xml · derivative · entry 6

Humeau Laurent · CIK 0001770390 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,855

Underlying: Common Stock · 3,856 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units is as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units is as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units is as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · derivative.underlying_shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F2 · balance_after: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:07 UTC
Humeau LaurentChief Scientific Officer
Exercise / conversionRestricted Stock Unit · Derivative 1,878 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000004 · wk-form4_1709158046.xml · derivative · entry 5

Humeau Laurent · CIK 0001770390 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,878 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F2 · shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F2 · derivative.underlying_shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:07 UTC
Humeau LaurentChief Scientific Officer
Tax withholdingCommon Stock 1,581 $8.16 $12,900.96
Disclosure

SEC source: 0001055726-24-000004 · wk-form4_1709158046.xml · nonDerivative · entry 4

Humeau Laurent · CIK 0001770390 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,269

F5 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (4) herein.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:07 UTC
Humeau LaurentChief Scientific Officer
Exercise / conversionCommon Stock 3,856 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-24-000004 · wk-form4_1709158046.xml · nonDerivative · entry 3

Humeau Laurent · CIK 0001770390 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,850

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units is as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:07 UTC
Humeau LaurentChief Scientific Officer
Tax withholdingCommon Stock 770 $8.16 $6,283.20
Disclosure

SEC source: 0001055726-24-000004 · wk-form4_1709158046.xml · nonDerivative · entry 2

Humeau Laurent · CIK 0001770390 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,994

F3 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:07 UTC
Humeau LaurentChief Scientific Officer
Exercise / conversionCommon Stock 1,878 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-24-000004 · wk-form4_1709158046.xml · nonDerivative · entry 1

Humeau Laurent · CIK 0001770390 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F2 · balance_after: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:06 UTC Exercise / conversionRestricted Stock Unit · Derivative 3,997 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000003 · wk-form4_1709157959.xml · derivative · entry 7

KIES PETER · CIK 0001259780 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,997

Underlying: Common Stock · 3,997 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,991 restricted stock units is as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,991 restricted stock units is as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,991 restricted stock units is as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F2 · derivative.underlying_shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F2 · balance_after: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:06 UTC Exercise / conversionRestricted Stock Unit · Derivative 1,878 $0.00 $0.00
Disclosure

SEC source: 0001055726-24-000003 · wk-form4_1709157959.xml · derivative · entry 6

KIES PETER · CIK 0001259780 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,878 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F2 · shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F2 · derivative.underlying_shares: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:06 UTC Tax withholdingCommon Stock 2,358 $8.16 $19,241.28
Disclosure

SEC source: 0001055726-24-000003 · wk-form4_1709157959.xml · nonDerivative · entry 4

KIES PETER · CIK 0001259780 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,158

F5 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (4) herein.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:06 UTC Exercise / conversionCommon Stock 3,997 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-24-000003 · wk-form4_1709157959.xml · nonDerivative · entry 3

KIES PETER · CIK 0001259780 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,516

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,991 restricted stock units is as follows: 3,997 shares vested on February 26, 2023; 3,997 shares vested on February 26, 2024; and 3,997 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:06 UTC Tax withholdingCommon Stock 1,108 $8.16 $9,041.28
Disclosure

SEC source: 0001055726-24-000003 · wk-form4_1709157959.xml · nonDerivative · entry 2

KIES PETER · CIK 0001259780 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,519

F3 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 22:06 UTC Exercise / conversionCommon Stock 1,878 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-24-000003 · wk-form4_1709157959.xml · nonDerivative · entry 1

KIES PETER · CIK 0001259780 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,627

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.

F2 · balance_after: Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 21:12 UTC
Sumner Michael JohnChief Medical Officer
Exercise / conversionRestricted Stock Unit · Derivative 35,000 $0.00 $0.00
Disclosure

SEC source: 0001055726-23-000045 · wk-form4_1688418758.xml · derivative · entry 2

Sumner Michael John · CIK 0001936799 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 35,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 105,000 restricted stock units is as follows: 35,000 shares vested on June 30, 2023; 35,000 shares will vest on June 30, 2024; 35,000 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 105,000 restricted stock units is as follows: 35,000 shares vested on June 30, 2023; 35,000 shares will vest on June 30, 2024; 35,000 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 105,000 restricted stock units is as follows: 35,000 shares vested on June 30, 2023; 35,000 shares will vest on June 30, 2024; 35,000 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 21:12 UTC
Sumner Michael JohnChief Medical Officer
Exercise / conversionCommon Stock 35,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-23-000045 · wk-form4_1688418758.xml · nonDerivative · entry 1

Sumner Michael John · CIK 0001936799 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 105,000 restricted stock units is as follows: 35,000 shares vested on June 30, 2023; 35,000 shares will vest on June 30, 2024; 35,000 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Read SEC document
June 05, 2023 Filed Jun 5, 2023 20:13 UTC
Zoth Lota S.Director
SaleCommon Stock 5,700 $0.56 $3,192.00
Disclosure

SEC source: 0001055726-23-000044 · wk-form4_1685995996.xml · nonDerivative · entry 1

Zoth Lota S. · CIK 0001278219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,716

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:57 UTC
Zoth Lota S.Director
Exercise / conversionRestricted Stock Unit · Derivative 19,000 $0.00 $0.00
Disclosure

SEC source: 0001055726-23-000039 · wk-form4_1684270611.xml · derivative · entry 2

Zoth Lota S. · CIK 0001278219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:57 UTC
Zoth Lota S.Director
Exercise / conversionCommon Stock 19,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-23-000039 · wk-form4_1684270611.xml · nonDerivative · entry 1

Zoth Lota S. · CIK 0001278219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,416

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:56 UTC Exercise / conversionRestricted Stock Unit · Derivative 19,000 $0.00 $0.00
Disclosure

SEC source: 0001055726-23-000038 · wk-form4_1684270551.xml · derivative · entry 2

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:56 UTC Exercise / conversionCommon Stock 19,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-23-000038 · wk-form4_1684270551.xml · nonDerivative · entry 1

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,153

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:54 UTC Exercise / conversionRestricted Stock Unit · Derivative 19,000 $0.00 $0.00
Disclosure

SEC source: 0001055726-23-000037 · wk-form4_1684270484.xml · derivative · entry 2

Weiner David B. · CIK 0001669080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:54 UTC Exercise / conversionCommon Stock 19,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-23-000037 · wk-form4_1684270484.xml · nonDerivative · entry 1

Weiner David B. · CIK 0001669080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 929,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:52 UTC Exercise / conversionRestricted Stock Unit · Derivative 19,000 $0.00 $0.00
Disclosure

SEC source: 0001055726-23-000035 · wk-form4_1684270316.xml · derivative · entry 2

BENITO SIMON X · CIK 0001273306 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:52 UTC Exercise / conversionCommon Stock 19,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-23-000035 · wk-form4_1684270316.xml · nonDerivative · entry 1

BENITO SIMON X · CIK 0001273306 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,305

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:53 UTC
Shepard JayDirector
Exercise / conversionRestricted Stock Unit · Derivative 19,000 $0.00 $0.00
Disclosure

SEC source: 0001055726-23-000036 · wk-form4_1684270397.xml · derivative · entry 2

Shepard Jay · CIK 0001587788 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:53 UTC
Shepard JayDirector
Exercise / conversionCommon Stock 19,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-23-000036 · wk-form4_1684270397.xml · nonDerivative · entry 1

Shepard Jay · CIK 0001587788 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,521

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:50 UTC Exercise / conversionRestricted Stock Unit · Derivative 19,000 $0.00 $0.00
Disclosure

SEC source: 0001055726-23-000034 · wk-form4_1684270239.xml · derivative · entry 2

Miller Ann Calby · CIK 0001771423 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:50 UTC Exercise / conversionCommon Stock 19,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-23-000034 · wk-form4_1684270239.xml · nonDerivative · entry 1

Miller Ann Calby · CIK 0001771423 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,534

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:48 UTC Exercise / conversionRestricted Stock Unit · Derivative 19,000 $0.00 $0.00
Disclosure

SEC source: 0001055726-23-000033 · wk-form4_1684270114.xml · derivative · entry 6

DANSEY ROGER D · CIK 0001741836 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document
May 16, 2023 Filed May 16, 2023 20:48 UTC Exercise / conversionCommon Stock 19,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001055726-23-000033 · wk-form4_1684270114.xml · nonDerivative · entry 2

DANSEY ROGER D · CIK 0001741836 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.